Plain-English translation of NCT07101237 on ClinicalTrials.gov ↗ ·
This research study is exploring new ways to diagnose and understand liver cancer by combining several advanced imaging techniques (special ultrasounds that show tumor blood flow and stiffness, and a newer technology called photoacoustic imaging) with genetic testing of tumor tissue. The goal is to create a personalized profile of each patient's cancer that will help doctors predict which treatments will work best and improve outcomes.
In China and worldwide, most liver cancer patients are diagnosed at advanced stages when standard treatments don't work well. This happens partly because cancers look similar under the microscope but behave very differently based on their genetics. This study aims to catch these differences early through imaging and genetic analysis so doctors can choose more targeted, effective treatments from the start.
You likely qualify if…
You likely don't qualify if…
As a participant, you would undergo several imaging scans using different types of ultrasound technology to examine your liver tumor in detail. You may also have tissue samples taken from your tumor (through biopsy or during surgery) for genetic and molecular analysis. These tests would happen before your scheduled surgery or treatment, and the imaging may take 30–60 minutes per session depending on the complexity of your case.
AI-generated summary from trial data · Jul 6, 2026 · Not medical advice
China